Parnax Lab Ltd (506128) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 506128 | NSE: | Pharmaceuticals & Drugs | Small Cap

Parnax Lab Share Price

112.95 -7.10 -5.91%
as on 05-Dec'25 12:17

Parnax Lab Ltd (506128) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 506128 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Parnax Lab

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Parnax Lab stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
172.36
Market Cap:
137.9 Cr.
52-wk low:
81
52-wk high:
185

Is Parnax Lab Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Parnax Lab: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Parnax Lab Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -1.1%1.4%-5.4%2.9%5%-2.6%7.8%8.9%12.5%8.6%-
Value Creation
Index
-1.1-0.9-1.4-0.8-0.6-1.2-0.4-0.4-0.1-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 7.25.35.86.57.72.47.27.57.475
Sales YoY Gr.--27%9.9%11.9%18.3%-69.1%201.7%4.5%-0.4%-5.7%-
Adj EPS -1.3-0.8-1.7-1-2.4-1.30.50.91.51.10.7
YoY Gr.-NANANANANANA89.8%62.4%-24.5%-
BVPS (₹) 13.712.910.29.26.95.511.116.918.419.620.3
Adj Net
Profit
-1.1-0.7-1.4-0.9-2.1-1.10.51.11.71.31
Cash Flow from Ops. 1.83.70.61.72.20.5-0.4-0.30.10.3-
Debt/CF from Ops. 9.53.319.46.7524.2-25.5-3.800-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -0.3%-1.8%-0.6%-5.7%
Adj EPS NANA32.5%-24.5%
BVPS4.1%23.4%20.8%6.6%
Share Price 9.5% 30.3% 14% -33.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-9.4-5.9-14.5-10.4-30.4-21.55.66.68.663.5
Op. Profit
Mgn %
-4.30.161.77-19.319.121.128.417.67.8
Net Profit
Mgn %
-15.8-12.6-24.6-13.2-27-47.76.814.323.318.614.7
Debt to
Equity
1.51.11.41.41.92.40.80.1000
Working Cap
Days
626527461485257389148222314442581
Cash Conv.
Cycle
44235517812261881949377515

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Parnax Lab Ltd.

Standalone Consolidated
TTM EPS (₹) 0.7 9.6
TTM Sales (₹ Cr.) 5.5 205
BVPS (₹.) 20.3 78.4
Reserves (₹ Cr.) 12 78
P/BV 5.93 1.53
PE 172.36 12.52
From the Market
52 Week Low / High (₹) 81.00 / 184.95
All Time Low / High (₹) 8.40 / 193.50
Market Cap (₹ Cr.) 138
Equity (₹ Cr.) 11.5
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Parnax Lab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *9.419.419.419.419.419.419.419.419.419.41
* Pledged shares as % of Promoter's holding (%)

Valuation of Parnax Lab - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Parnax Lab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales7566827777
Operating Expenses 8576736656
Manufacturing Costs2111101011
Material Costs3333413333
Employee Cost 1110101111
Other Costs 1132211111
Operating Profit -00-101-01221
Operating Profit Margin (%) -5.6%0.0%-19.1%1.7%7.0%-19.3%19.1%21.0%28.4%17.6%
Other Income 1101000011
Interest 1111111000
Depreciation 1100000000
Exceptional Items 0000000000
Profit Before Tax -1-1-2-1-0-11222
Tax -0-0-002-00010
Profit After Tax -1-1-2-1-2-11121
PAT Margin (%) -14.0%-12.6%-41.4%-12.7%-26.1%-47.7%7.6%16.1%24.5%19.9%
Adjusted EPS (₹)-1.2-0.8-2.8-1.0-2.4-1.30.61.11.61.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 1211986511192123
Share Capital 99999910111111
Reserves 320-1-3-4181011
Minority Interest0000000000
Debt1510121111118000
Long Term Debt13788321000
Short Term Debt2342897000
Trade Payables0111111011
Others Liabilities 10-2-1-0-02101
Total Liabilities 28222018181622212225

Fixed Assets

Gross Block16711111111
Accumulated Depreciation10100000111
Net Fixed Assets 7611100000
CWIP 0000000000
Investments 11101010101010101010
Inventories0000011111
Trade Receivables7343202111
Cash Equivalents 000-1004101
Others Assets 215555571011
Total Assets 28222018181622212225

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 241220-0-000
PBT -1-1-2-1-0-11222
Adjustment 12311110-0-0
Changes in Working Capital 23-1111-2-2-2-1
Tax Paid -00000-0-0-0-0-0
Cash Flow From Investing Activity -0000-00000-0
Capex -0-000-000-0-00
Net Investments 01-0-00-0-00-0-1
Others 0000000001
Cash Flow From Financing Activity -2-4-1-2-2-05-3-1-0
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing -20-00-6-1-1-1-00
Interest Paid 0-1-1-1-1-1-1-0-0-0
Dividend Paid 0000000000
Others -0-3-0-2616-2-10
Net Cash Flow -00-0-11-04-3-10

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-8.38-5.9-24.44-10.04-29.37-21.496.927.9596.38
ROCE (%)-1.141.42-5.432.855.04-2.577.88.8512.458.61
Asset Turnover Ratio0.240.210.270.340.430.140.370.350.350.3
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/A-0-000
Working Capital Days
Receivable Days46037523318410919259724137
Inventory Days44202123145635333644
Payable Days16173136124812731238369125

Parnax Lab Ltd Stock News

Parnax Lab Ltd FAQs

The current trading price of Parnax Lab on 05-Dec-2025 12:17 is ₹113.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Parnax Lab stood at ₹137.9.
The latest P/E ratio of Parnax Lab as of 04-Dec-2025 is 172.4.
The latest P/B ratio of Parnax Lab as of 04-Dec-2025 is 5.93.
The 52-week high of Parnax Lab is ₹184.9 and the 52-week low is ₹81.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Parnax Lab is ₹5.49 ( Cr.) .

About Parnax Lab Ltd

Parnax Lab, earlier known as Krishnadeep Trade and Investments, incorporated in the year 1982, engages in investing and financial businesses in India. The company is based in Mumbai, India. In 2012 the company has changed its name from Krishna Deep Trade & Investments Ltd. to Parnax Lab Ltd.                                              "

In 2009, Krishna Deep Trade and Investments appointed Rasik Chaturvedi and Dilip Pimparkar as additional directors of the company with effect from February 16, 2009. Further, Rasik Chaturvedi and Dilip Pimparkar have also been inducted on the Audit Committee of the Company.

The registered office of the company is 136, Greet Western Building, Nagindas Master Road Extension, Fort Mumbai, Maharashtra-400001.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×